Parkman Healthcare Partners LLC - KEROS THERAPEUTICS INC ownership

KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 129 filers reported holding KEROS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parkman Healthcare Partners LLC ownership history of KEROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,515,383
-14.4%
298,475
+7.8%
1.74%
-9.5%
Q2 2023$11,122,427
+45.3%
276,815
+54.4%
1.93%
+15.8%
Q1 2023$7,655,683
+25.7%
179,290
+41.4%
1.66%
+2.7%
Q4 2022$6,088,456
+62.0%
126,790
+26.9%
1.62%
+51.6%
Q3 2022$3,759,000
+184.8%
99,927
+109.1%
1.07%
+120.0%
Q2 2022$1,320,000
-66.6%
47,788
-34.3%
0.49%
-58.0%
Q1 2022$3,953,000
-3.3%
72,690
+4.0%
1.16%
+28.3%
Q4 2021$4,088,00069,8610.90%
Other shareholders
KEROS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
CHI Advisors LLC 407,633$12,995,3405.15%
Opaleye Management Inc. 360,400$11,489,5523.74%
Parkman Healthcare Partners LLC 298,475$9,515,3831.74%
BRAIDWELL LP 1,357,309$43,271,0111.37%
First Light Asset Management, LLC 421,438$13,435,4431.28%
Orbimed Advisors 1,514,734$48,289,7201.03%
Yiheng Capital Management, L.P. 554,151$17,666,3340.90%
Nantahala Capital Management 328,781$10,481,5380.90%
DAFNA Capital Management LLC 65,961$2,102,8370.65%
EDBI Pte Ltd 10,105$322,1470.35%
View complete list of KEROS THERAPEUTICS INC shareholders